KPV 15mg

$59.99

  • Compound: KPV 15mg
  • Sequence: Lys-Pro-Val
  • Molecular Formula: C₁₆H₃₀N₄O₄
  • Molecular Weight: 342.43 g/mol
  • CAS Number: 67727-97-3
  • Vial Size: 3mL
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPKPV15 Categories: , Tag:
Description

KPV 15mg – Advanced Peptide Research Material

KPV 15mg from OROS Research is a tripeptide research material supplied in a 3mL vial. The provided specifications identify the sequence as Lys-Pro-Val, with molecular formula C₁₆H₃₀N₄O₄, molecular weight 342.43 g/mol, and CAS number 67727-97-3.

The 15mg format provides a defined quantity for controlled experimental investigation. Researchers should establish appropriate concentrations, controls, analytical methods, and endpoints according to independently validated laboratory protocols.

KPV 15mg Research Overview

The supplied sequence consists of three amino-acid residues:

Lys-Pro-Val

Its defined sequence and molecular specifications provide reference information for laboratory documentation, analytical investigation, and scientific literature searches.

Research findings involving this material should be interpreted according to the experimental model, methodology, concentration, controls, and endpoints described in the original study.

Product Specifications

Specification Product Information
Compound KPV 15mg
Sequence Lys-Pro-Val
Molecular Formula C₁₆H₃₀N₄O₄
Molecular Weight 342.43 g/mol
CAS Number 67727-97-3
Vial Size 3mL
Research Setting Laboratory investigation
Personal Use Not intended

PubChem note: The supplied product information lists PubChem CID 125672, while the provided PubChem link points to compound 56841945. Because these identifiers conflict, a definitive PubChem CID is not asserted here without independent verification.

Molecular Characteristics and Research Identification

The supplied molecular formula is C₁₆H₃₀N₄O₄, with a stated molecular weight of 342.43 g/mol.

The supplied CAS number is 67727-97-3.

These identifiers, together with the Lys-Pro-Val sequence, can support accurate laboratory documentation and comparison with appropriately matched scientific literature.

Researchers should verify molecular identifiers when connecting a physical research material to external database records.

KPV Peptide Dosage Chart – Research Context

The phrase kpv peptide dosage chart reflects search interest related to quantity and administration information.

This research listing does not provide a human dosage chart, injection schedule, treatment plan, or self-administration instructions.

For controlled laboratory experiments, researchers should determine experimental concentrations from the requirements of the research model, validated methodology, assay design, and applicable scientific literature.

The stated 15mg describes the quantity of research material supplied in the vial. It is not a recommended human dose.

KPV Peptide Dosage Per Day

The search phrase kpv peptide dosage per day similarly reflects interest in daily administration.

No daily human dosing recommendation is provided on this page.

Within laboratory investigation, exposure quantity and frequency are experimental variables that should be established according to the applicable protocol. Researchers should document these conditions alongside controls and analytical endpoints to support reproducibility.

Product quantity should therefore not be interpreted as an administration schedule.

KPV Peptide Benefit – Scientific Research Context

Searches for kpv peptide benefit may reflect interest in why this tripeptide is investigated scientifically.

Rather than presenting therapeutic benefits, this page distinguishes research significance from health claims.

Scientific investigation may examine biochemical, molecular, or cellular responses involving the material under controlled experimental conditions. The relevance of any observed effect depends on the model, concentration, methodology, controls, and limitations of the individual study.

Published experimental observations should not automatically be interpreted as demonstrated benefits for people.

KPV Peptide Oral – Search Intent

The phrase kpv peptide oral reflects another type of search associated with this research material.

This page does not provide oral administration, consumption, formulation, dosing, or personal-use instructions.

For laboratory research, investigators should use preparation and exposure methods appropriate to their validated experimental model.

Information from studies involving a particular route, model, or formulation should also not be generalized to other experimental conditions without supporting evidence.

Laboratory Research Considerations

Controlled investigation involving this tripeptide should use clearly documented experimental methodology.

Important considerations can include:

  • Exact material identification
  • Experimental concentration
  • Research model selection
  • Appropriate controls
  • Sample preparation
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints
  • Reproducibility
  • Data interpretation

Researchers should also distinguish among in-vitro, animal, and human research when reviewing scientific literature.

Findings from one research population or model should be interpreted within its original context rather than assumed to apply universally.

Related OROS Research Materials

Researchers exploring additional materials can review DSIP 5mg as a separately specified research product.

Another catalog option is Epithalon (Epitalon) 10mg, which should be evaluated according to its own specifications and research context.

Researchers can also explore FOX04-DRI 10mg for independently designed laboratory investigations.

These products are linked for research-catalog navigation and should not be interpreted as chemically or experimentally interchangeable.

Scientific Research Resources

Researchers can use PubChem to investigate available chemical records and verify molecular identifiers.

Peer-reviewed biomedical and experimental literature can be explored through PubMed.

Database records and published studies should be matched carefully to the exact material being investigated before their findings are applied to experimental interpretation.

KPV 15mg Research FAQ

What is KPV 15mg?

It is a tripeptide research material supplied at a 15mg quantity in a 3mL vial.

What is the supplied sequence?

The sequence is Lys-Pro-Val.

What is the molecular formula?

The supplied molecular formula is C₁₆H₃₀N₄O₄.

What is the molecular weight?

The stated molecular weight is 342.43 g/mol.

What is the CAS number?

The supplied CAS number is 67727-97-3.

What is the vial size?

The material is supplied in a 3mL vial.

Does the 15mg specification represent a dosage?

No. It identifies the quantity of research material supplied and should not be interpreted as a recommended human dose or administration amount.

Is this product intended for human use?

No. This material is supplied exclusively for controlled laboratory investigation and is not intended for human or animal consumption, injection, oral administration, therapeutic application, self-administration, or veterinary use.

Research Use Disclaimer

This 15mg peptide material is supplied exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. It is not intended for human or animal consumption, injection, oral administration, therapeutic application, diagnosis, clinical use, self-administration, performance enhancement, or veterinary application. Experimental work should be performed by qualified personnel using appropriately validated laboratory procedures.

Additional information
Net Weight

15mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “KPV 15mg”

Your email address will not be published. Required fields are marked *